Company Filing History:
Years Active: 2025
Title: Fereshteh Parviz: Innovator in Cancer Treatment
Introduction
Fereshteh Parviz is a prominent inventor based in San Diego, California. She has made significant contributions to the field of cancer treatment through her innovative research and development of novel therapeutic methods.
Latest Patents
Fereshteh Parviz holds a patent for "Primary NK CAR constructs and methods." This patent discloses recombinant nucleic acids that include a 5' untranslated (5′-UTR) sequence portion, a signal peptide sequence portion, a single chain antibody fragment sequence portion, a hinge region sequence portion, a transmembrane domain sequence portion, and one or more intracellular domain sequence portions. Additionally, the patent describes modified natural killer (NK) cells that incorporate the aforementioned recombinant nucleic acid. The methods outlined in the patent focus on treating tumors in subjects by administering these modified NK cells.
Career Highlights
Fereshteh Parviz is currently employed at ImmunityBio, Inc., where she continues her groundbreaking work in immunotherapy. Her research has the potential to revolutionize cancer treatment and improve patient outcomes.
Collaborations
Fereshteh collaborates with various professionals in her field, including her coworker Rohit Duggal. Together, they work on advancing the understanding and application of NK cell therapies.
Conclusion
Fereshteh Parviz is a trailblazer in the field of cancer treatment, with her innovative patent and ongoing research at ImmunityBio, Inc. Her work exemplifies the impact of scientific innovation on healthcare.